article thumbnail

Episode 275: Anti-Racism in Medicine Series – Episode 19 – Reframing the Opioid Epidemic: Anti-Racist Praxis, Racial Health Inequities, and Harm Reduction

The Clinical Problem Solvers

Between 2007 – 2019, Black individuals experienced a higher death rate for opioid overdose deaths than any other racial or ethnic group. These narratives have vilified individuals who would benefit from comprehensive, person-centered substance use treatment, rather than incarceration and other adverse harms.

article thumbnail

EMS Intervention to Reduce Falls: Carmen Quatman and Katie Quatman-Yates

GeriPal

Wait, first of all, what’s the incidence of calling EMS for falls over almost a decade, I think like 2007 to 2016, and what happens to people afterwards? So what we found is up to 30% of people would call 911 again for a fall, and of those calls, some people became very high-utilizers and so they would call 911 over and over again.

Community 115
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

RCT of PC in ED: Corita Grudzen, Fernanda Bellolio, & Tammie Quest

GeriPal

It was really at the level of the ED across 33 EDs in random order, and then tried to see if we could make a difference in healthcare utilization, primarily the primary outcome was admission to the hospital, acute care admission. Would it have changed potentially utilization rates like hospice utilization? That is safe.

article thumbnail

FDA-Approved Labeling: Is Enough Enough?

FDA Law Blog

FDA did, however, try to identify safety issues through the medical literature and (after 2007 when mandatory safety reporting for OTC human drug products marketed without an approved application became effective) through the adverse event reporting system. A recent state law failure-to-warn case in the SDNY makes that very point.

article thumbnail

Ding Dong is the Skinny Label (Effectively) Dead?

FDA Law Blog

Teva received tentative approval in June 2003 and launched in 2007 after a blocking patent expired. Especially now with the utility of the use code minimized. Teva submitted an ANDA in 2002, and after some complicated regulatory history, ultimately carved-out the congestive heart failure indication by way of a section viii statement.

IT 52
article thumbnail

Navigating Insulin Initiation in Type 2 Diabetes: Unraveling the Sociodemographic and Biological Dynamics [Diabetes and endocrine disease]

Annals of Family Medicine

Objective: This study aimed to investigate factors affecting insulin prescription patterns in individuals with T2DM. Study Design and Analysis: A cohort design using routine care data, we utilized Fine and Gray’s survival analysis to examine time-to-insulin initiation while accounting for death as a competing event.

Diabetes 130
article thumbnail

Health and Wealth Shocks: Lauren Hunt, Rebecca Rodin, Tsai-Chin Cho

GeriPal

Those are all things that could dramatically be a major health shock for an individual. And we interestingly did not really see any change in function in those individuals, which has somewhat been reported in some places elsewhere, which makes one wonder if they maybe weren’t accounting for serious illness in some of those populations.

Illness 73